Viewing Study NCT00544232


Ignite Creation Date: 2025-12-24 @ 9:42 PM
Ignite Modification Date: 2026-02-24 @ 5:02 AM
Study NCT ID: NCT00544232
Status: COMPLETED
Last Update Posted: 2016-02-15
First Post: 2007-10-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE)
Sponsor: GBG Forschungs GmbH
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Breast Cancer View
None neoadjuvant therapy View
None pCR rates View